DEXCOM INC — Director's Dealing 2020

Mar 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-03-08

Reporting Person: Sylvain Jereme M (SVP, Finance & CAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-08	Common Stock	A	5483	$0.001	Acquired	14030	Direct

Footnotes

F1: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2: Included in this number are 11,247 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 3,216 of which were granted on March 8, 2019 and shall vest through March 8, 2022 and 2,548 of which were granted on November 8, 2018 and shall vest through November 8, 2021.